Medicus Pharma Ltd. Stock Price

NasdaqCM:MDCX Community·US$47.1m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
4 Fair Values set on narratives written by author

Create a narrative

MDCX Share Price Performance

US$2.42

-2.32 (-48.94%)

US$2.42

-2.32 (-48.94%)

US$2.42

Fri, 7 Nov 25

Share PriceUS$2.42

MDCX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Excellent balance sheet with moderate risk.

5 Risks

2 Rewards

View Full Analysis

Medicus Pharma Ltd. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.84
: 0%
: 0%
: 144.7%

View Full Analysis

About MDCX

Founded: 2008
Employees: n/a
CEO: Raza Bokhari
WebsiteView website: medicuspharma.com

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.